(BCS) Barclays - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US06738E2046
Stock: Retail Banking, Credit Cards, Investment Banking, Wealth Management, Lending
Total Rating 52
Risk 63
Buy Signal 0.27
| Risk 5d forecast | |
|---|---|
| Volatility | 33.0% |
| Relative Tail Risk | 3.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.89 |
| Alpha | 60.53 |
| Character TTM | |
|---|---|
| Beta | 1.123 |
| Beta Downside | 1.202 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.08% |
| CAGR/Max DD | 2.00 |
EPS (Earnings per Share)
Revenue
Description: BCS Barclays January 27, 2026
Barclays PLC (NYSE: BCS) is a globally diversified financial services firm headquartered in London, operating across retail banking, credit cards, wholesale and investment banking, wealth management, and investment management. Its business is organized into five segments: Barclays UK, Barclays UK Corporate Bank, Barclays Private Bank & Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank.
In its latest reporting (Q4 2025), Barclays posted a net profit of $5.9 billion, a 7% year-over-year increase, driven by a 4% rise in loan book growth and a 12% lift in fee-based income. The bank’s Common Equity Tier 1 (CET1) ratio improved to 13.2%, reflecting a stronger capital position amid tightening European banking regulations. Key sector drivers include the Bank of England’s policy rate at 5.25%-supporting net interest margins-and accelerating digital adoption, with 55% of UK retail transactions now processed via mobile channels, outpacing the industry average of 48%.
For a deeper quantitative assessment, explore the detailed metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 7.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -0.89 > 1.0 |
| NWC/Revenue: -1032 % < 20% (prev -613.8%; Δ -417.9% < -1%) |
| CFO/TA 0.03 > 3% & CFO 39.04b > Net Income 7.17b |
| Net Debt (-58.99b) to EBITDA (9.78b): -6.03 < 3 |
| Current Ratio: 0.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.47b) vs 12m ago -9.09% < -2% |
| Gross Margin: 22.80% > 18% (prev -0.01%; Δ 2281 % > 0.5%) |
| Asset Turnover: 1.83% > 50% (prev 1.66%; Δ 0.18% > 0%) |
| Interest Coverage Ratio: 0.27 > 6 (EBITDA TTM 9.78b / Interest Expense TTM 21.21b) |
Altman Z'' -1.03
| A: -0.19 (Total Current Assets 407.84b - Total Current Liabilities 697.65b) / Total Assets 1544.16b |
| B: 0.04 (Retained Earnings 59.25b / Total Assets 1544.16b) |
| C: 0.00 (EBIT TTM 5.63b / Avg Total Assets 1531.18b) |
| D: 0.05 (Book Value of Equity 77.07b / Total Liabilities 1465.93b) |
| Altman-Z'' Score: -1.03 = CCC |
Beneish M
| DSRI: none (Receivables 276.0m/none, Revenue 28.09b/25.14b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.11 (AQ_t 0.73 / AQ_t-1 0.66) |
| SGI: 1.12 (Revenue 28.09b / 25.14b) |
| TATA: -0.02 (NI 7.17b - CFO 39.04b) / TA 1544.16b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of BCS shares?
As of February 23, 2026, the stock is trading at USD 25.99 with a total of 6,480,527 shares traded.
Over the past week, the price has changed by +1.28%, over one month by +0.62%, over three months by +24.49% and over the past year by +78.55%.
Over the past week, the price has changed by +1.28%, over one month by +0.62%, over three months by +24.49% and over the past year by +78.55%.
Is BCS a buy, sell or hold?
Barclays has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy BCS.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.4 | 5.4% |
| Analysts Target Price | 27.4 | 5.4% |
BCS Fundamental Data Overview February 21, 2026
Market Cap GBP = 66.39b (89.32b USD * 0.7433 USD.GBP)
P/E Trailing = 11.2652
P/E Forward = 8.7184
P/S = 3.3305
P/B = 0.8239
P/EG = 1.453
Revenue TTM = 28.09b GBP
EBIT TTM = 5.63b GBP
EBITDA TTM = 9.78b GBP
Long Term Debt = 131.99b GBP (from longTermDebt, last quarter)
Short Term Debt = 73.13b GBP (from shortTermDebt, last quarter)
Debt = 170.76b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -58.99b GBP (from netDebt column, last quarter)
Enterprise Value = -170.41b GBP (66.39b + Debt 170.76b - CCE 407.56b)
Interest Coverage Ratio = 0.27 (Ebit TTM 5.63b / Interest Expense TTM 21.21b)
EV/FCF = 21.12x (Enterprise Value -170.41b / FCF TTM -8.07b)
FCF Yield = 4.74% (FCF TTM -8.07b / Enterprise Value -170.41b)
FCF Margin = -28.73% (FCF TTM -8.07b / Revenue TTM 28.09b)
Net Margin = 25.53% (Net Income TTM 7.17b / Revenue TTM 28.09b)
Gross Margin = 22.80% ((Revenue TTM 28.09b - Cost of Revenue TTM 21.69b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = -0.11 (set to none) (Enterprise Value -170.41b / Total Assets 1544.16b)
Interest Expense / Debt = 12.42% (Interest Expense 21.21b / Debt 170.76b)
Taxrate = 20.87% (388.0m / 1.86b)
NOPAT = 4.45b (EBIT 5.63b * (1 - 20.87%))
Current Ratio = 0.58 (Total Current Assets 407.84b / Total Current Liabilities 697.65b)
Debt / Equity = 2.20 (Debt 170.76b / totalStockholderEquity, last quarter 77.78b)
Debt / EBITDA = -6.03 (Net Debt -58.99b / EBITDA 9.78b)
Debt / FCF = 7.31 (negative FCF - burning cash) (Net Debt -58.99b / FCF TTM -8.07b)
Total Stockholder Equity = 76.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.47% (Net Income 7.17b / Total Assets 1544.16b)
RoE = 9.41% (Net Income TTM 7.17b / Total Stockholder Equity 76.24b)
RoCE = 2.70% (EBIT 5.63b / Capital Employed (Equity 76.24b + L.T.Debt 131.99b))
RoIC = 2.04% (NOPAT 4.45b / Invested Capital 218.27b)
WACC = 9.89% (E(66.39b)/V(237.15b) * Re(10.05%) + D(170.76b)/V(237.15b) * Rd(12.42%) * (1-Tc(0.21)))
Discount Rate = 10.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -52.04%
Fair Price DCF = unknown (Cash Flow -8.07b)
EPS Correlation: 24.15 | EPS CAGR: -0.85% | SUE: -0.02 | # QB: 0
Revenue Correlation: 30.40 | Revenue CAGR: 0.01% | SUE: -0.24 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.82 | Chg30d=-0.036 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=2.97 | Chg30d=+0.017 | Revisions Net=+1 | Growth EPS=+27.7% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=3.55 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+19.7% | Growth Revenue=+4.2%
P/E Trailing = 11.2652
P/E Forward = 8.7184
P/S = 3.3305
P/B = 0.8239
P/EG = 1.453
Revenue TTM = 28.09b GBP
EBIT TTM = 5.63b GBP
EBITDA TTM = 9.78b GBP
Long Term Debt = 131.99b GBP (from longTermDebt, last quarter)
Short Term Debt = 73.13b GBP (from shortTermDebt, last quarter)
Debt = 170.76b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -58.99b GBP (from netDebt column, last quarter)
Enterprise Value = -170.41b GBP (66.39b + Debt 170.76b - CCE 407.56b)
Interest Coverage Ratio = 0.27 (Ebit TTM 5.63b / Interest Expense TTM 21.21b)
EV/FCF = 21.12x (Enterprise Value -170.41b / FCF TTM -8.07b)
FCF Yield = 4.74% (FCF TTM -8.07b / Enterprise Value -170.41b)
FCF Margin = -28.73% (FCF TTM -8.07b / Revenue TTM 28.09b)
Net Margin = 25.53% (Net Income TTM 7.17b / Revenue TTM 28.09b)
Gross Margin = 22.80% ((Revenue TTM 28.09b - Cost of Revenue TTM 21.69b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = -0.11 (set to none) (Enterprise Value -170.41b / Total Assets 1544.16b)
Interest Expense / Debt = 12.42% (Interest Expense 21.21b / Debt 170.76b)
Taxrate = 20.87% (388.0m / 1.86b)
NOPAT = 4.45b (EBIT 5.63b * (1 - 20.87%))
Current Ratio = 0.58 (Total Current Assets 407.84b / Total Current Liabilities 697.65b)
Debt / Equity = 2.20 (Debt 170.76b / totalStockholderEquity, last quarter 77.78b)
Debt / EBITDA = -6.03 (Net Debt -58.99b / EBITDA 9.78b)
Debt / FCF = 7.31 (negative FCF - burning cash) (Net Debt -58.99b / FCF TTM -8.07b)
Total Stockholder Equity = 76.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.47% (Net Income 7.17b / Total Assets 1544.16b)
RoE = 9.41% (Net Income TTM 7.17b / Total Stockholder Equity 76.24b)
RoCE = 2.70% (EBIT 5.63b / Capital Employed (Equity 76.24b + L.T.Debt 131.99b))
RoIC = 2.04% (NOPAT 4.45b / Invested Capital 218.27b)
WACC = 9.89% (E(66.39b)/V(237.15b) * Re(10.05%) + D(170.76b)/V(237.15b) * Rd(12.42%) * (1-Tc(0.21)))
Discount Rate = 10.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -52.04%
Fair Price DCF = unknown (Cash Flow -8.07b)
EPS Correlation: 24.15 | EPS CAGR: -0.85% | SUE: -0.02 | # QB: 0
Revenue Correlation: 30.40 | Revenue CAGR: 0.01% | SUE: -0.24 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.82 | Chg30d=-0.036 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=2.97 | Chg30d=+0.017 | Revisions Net=+1 | Growth EPS=+27.7% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=3.55 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+19.7% | Growth Revenue=+4.2%